110 related articles for article (PubMed ID: 20823917)
1. [Synthesis and properties of the myelopeptides with differentiating activity].
Fonina LA; Kudriavtseva EV; Bespalova ZhD; Efremov MA; Mikhaĭlova AA; Kirilina EA
Bioorg Khim; 2010; 36(4):493-7. PubMed ID: 20823917
[TBL] [Abstract][Full Text] [Related]
2. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
Petrov RV; Mikhaĭlova AA; Fonina LA
Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
[TBL] [Abstract][Full Text] [Related]
3. [Tertiary structure of myelopeptides. II. Conformational analysis of Phe-Arg-Pro-Arg-Ile-Met-Thr-Pro, Val-Val-Tyr-Pro-Asp, and Val-Asp-Pro-Pro].
Ismailova LI; Akhmetov NA; Abbasly RM; Godzhaev NM
Bioorg Khim; 2005; 31(2):140-6. PubMed ID: 15889787
[TBL] [Abstract][Full Text] [Related]
4. [Myelopeptides: isolation and structure].
Fonina LA; Gur'ianov SA; Efremov MA; Smirnova OV
Bioorg Khim; 1998 Jun; 24(6):403-7. PubMed ID: 9702349
[TBL] [Abstract][Full Text] [Related]
5. A new endogenous differentiating factor (myelopeptide-4) for myeloid cells.
Strelkov LA; Mikhailova AA; Fonina LA; Petrov RV
FEBS Lett; 2000 Mar; 470(3):281-4. PubMed ID: 10745082
[TBL] [Abstract][Full Text] [Related]
6. Multiple anchoring of myelopeptides on sequential oligopeptide carriers (SOC(n)): synthesis, conformation and studies in human leukemia cells.
Keramisanou D; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Mikhailova AA; Strelkov LA
J Pept Res; 2002 Sep; 60(3):178-85. PubMed ID: 12213127
[TBL] [Abstract][Full Text] [Related]
7. [Fluorescently labeled differentiating myelopeptide-4: specific binding to and penetration into target cells].
Gur'ianov SA; Kirilina EA; Khaĭdukov SV; Suvorov NI; Molotkovskaia IM; Mikhaĭlova AA
Bioorg Khim; 2006; 32(6):574-8. PubMed ID: 17180907
[TBL] [Abstract][Full Text] [Related]
8. Myelopeptides: bone marrow regulatory mediators.
Petrov RV; Mikhailova AA; Fonina LA
Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
[TBL] [Abstract][Full Text] [Related]
9. [Spatial structure of myelopeptides: I. Conformational analysis of MP-1, MP-2, and MP-3].
Akhmetov NA; Ismailova LI; Abbasly RM; Akhmedov NF; Godzhaev NM
Bioorg Khim; 2005; 31(1):31-8. PubMed ID: 15787211
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and properties of the retro-analogue of myelopeptide MP-2].
Fonina LA; Ovchinnikov MV; Gur'ianov SA; Sychev SV; Belevskaia RG; Treshchalina EM
Bioorg Khim; 2005; 31(3):239-44. PubMed ID: 16004381
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
Petrov RV; Mikhailova AA; Fonina LA
Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
[TBL] [Abstract][Full Text] [Related]
12. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
Fonina LA; Az'muko AA; Kalikhevich VN; Levit ML; Ardemasova ZA; Gur'ianov SA; Belevskaia RG; Efremov MA; Treshchalina EM; Mikhaĭlova AA
Bioorg Khim; 2008; 34(4):451-6. PubMed ID: 18695716
[TBL] [Abstract][Full Text] [Related]
13. Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).
Mikhailova A; Fonina L; Kirilina E; Gur'yanov S; Efremov M; Petrov R
Regul Pept; 2003 Jul; 114(2-3):183-7. PubMed ID: 12832108
[TBL] [Abstract][Full Text] [Related]
14. Myelopeptides: new immunoregulatory peptides.
Petrov R
Allergy Proc; 1995; 16(4):177-84. PubMed ID: 8566725
[TBL] [Abstract][Full Text] [Related]
15. [Myelopeptides as a new group of regulatory peptides].
Mikhaĭlova AA
Vestn Ross Akad Med Nauk; 1999; (4):49-52. PubMed ID: 10377885
[TBL] [Abstract][Full Text] [Related]
16. [Effect of myelopeptides on the synthesis of DNA and total protein in the cells of the lymphoid organs in the mouse].
Strelkov LA; Stepanenko RN; Mikhaĭlova AA
Biull Eksp Biol Med; 1987 Dec; 104(12):703-6. PubMed ID: 3689965
[TBL] [Abstract][Full Text] [Related]
17. The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T lymphocytes.
Strelkov LA; Mikhailova AA; Sapozhnikov AM; Fonina LA; Petrov RV
Immunol Lett; 1996 May; 50(3):143-7. PubMed ID: 8803611
[TBL] [Abstract][Full Text] [Related]
18. [Protective Effects of Myelopeptides in Neuroblastoma C-1300 Cell Culture].
Pankova TM; Sapoznikov AM; Starostina MV
Bioorg Khim; 2015; 41(3):375-9. PubMed ID: 26502614
[TBL] [Abstract][Full Text] [Related]
19. Primary and tertiary structure of the principal human adenylate kinase.
Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
[TBL] [Abstract][Full Text] [Related]
20. Tachykinins and other biologically active peptides from the skin of the Costa Rican phyllomedusid frog Agalychnis callidryas.
Mignogna G; Severini C; Erspamer GF; Siciliano R; Kreil G; Barra D
Peptides; 1997; 18(3):367-72. PubMed ID: 9145422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
